• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Samuel A. Fisher Farm 9/13/13

  

Department of Health and Human Services logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration
 PHILADELPHIA DISTRICT
900 U.S. Customhouse
2nd and Chestnut Streets
Philadelphia, PA 19106
Telephone: 215-597-4390 

 

 WARNING LETTER
13-PHI-30
 
Via United Parcel Service
 
September 13, 2013
 
 
Mr. Samuel A. Fisher, Co-Owner
Samuel A. Fisher Farm
2100 Stiegel Pike
Myerstown, Pennsylvania 17067
 
Dear Mr. Fisher:
 
On July 23 and 29, 2013, the U.S. Food and Drug Administration (FDA) conducted an investigation of your dairy operation located at 2100 Stiegel Pike, Myerstown, Pennsylvania 17067. This letter notifies you of the violations of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) that we found during our investigation of your dairy operation. You can find the FD&C Act and its associated regulations on the Internet through links on FDA’s web page at www.fda.gov
 
We found that you offered for sale an animal for slaughter as food that was adulterated. Under section 402(a)(2)(C)(ii) of the FD&C Act, 21 U.S.C. 342(a)(2)(C)(ii), a food is deemed to be adulterated if it bears or contains a new animal drug that is unsafe under section 512 of the FD&C Act, 21 U.S.C. 360b. Further, under section 402(a)(4) of the FD&C Act, 21 U.S.C. 342(a)(4), a food is deemed to be adulterated if it has been held under insanitary conditions whereby it may have been rendered injurious to health.
 
Specifically, our investigation revealed that on or about October 12, 2012, you sold a culled dairy cow named (b)(4), later identified with tag (b)(4), for slaughter as food. On or about October 15, 2012, (b)(4), slaughtered this animal. United States Department of Agriculture, Food Safety and Inspection Service (USDA/FSIS) analysis of tissue samples collected from this animal identified the presence of sulfadimethoxine at (b)(4) parts per million (ppm) in the liver tissue. FDA has established a tolerance of 0.1 ppm for residues of sulfadimethoxine in the edible tissues of cattle as codified in Title 21, Code of Federal Regulations (C.F.R.), Section 556.640 (21 C.F.R. 556.640). The presence of this drug in edible tissue from this animal in these amounts causes the food to be adulterated within the meaning of section 402(a)(2)(C)(ii) of the FD&C Act, 21 U.S.C. § 342(a)(2)(C)(ii).
 
Our investigation also found that you hold animals under conditions that are so inadequate that medicated animals bearing potentially harmful drug residues are likely to enter the food supply. For example, you failed to maintain complete treatment records. Food from animals held under such conditions is adulterated within the meaning of section 402(a)(4) of the FD&C Act, 21 U.S.C. 342(a)(4).
 
We also found that you adulterated the new animal drug Albon (sulfadimethoxine,15g bolus, NADA #031-715). Specifically, our investigation revealed that you did not use Albon as directed by its approved labeling.  Use of this drug in this manner is an extralabel use. See 21 C.F.R. 530.3(a). We have enclosed a copy for your reference.
 
The extralabel use of approved animal or human drugs in animals is allowed under the FD&C Act only if the extralabel use complies with sections 512(a)(4) and (5) of the FD&C Act, 21 U.S.C. 360b(a)(4) and (5), and 21 C.F.R. Part 530, including that the use must be by or on the lawful order of a licensed veterinarian within the context of a valid veterinarian/client/patient relationship. 
 
Our investigation found that you administered Albon (sulfadimethoxine,15g bolus, NADA #031-715) to a culled dairy cow identified with tag (b)(4) without following the withdrawal period as stated in the approved labeling. In addition, the Albon drug you identified as the same one administered to the cow identified with tag (b)(4), had an expiration date on the label of December 2008. Your extralabel use of Albon was not under the supervision of a licensed veterinarian, in violation of 21 C.F.R. 530.11(a), and your extralabel use of Albon resulted in an illegal drug residue, in violation of 21 C.F.R. 530.11(d). Because your use of this drug was not in conformance with its approved labelingand did not comply with 21 C.F.R. Part 530, you caused the drug to beunsafe under section 512(a) of the FD&C Act, 21 U.S.C. 360b(a), and adulterated within the meaning of section 501(a)(5) of the FD&C Act, 21 U.S.C. 351(a)(5).
 
The above is not intended to be an all-inclusive list of violations. As a producer of animals offered for use as food, you are responsible for ensuring that your overall operation and the food you distribute is in compliance with the law.
 
You should take prompt action to correct the violations described in this letter and to establish procedures to ensure that these violations do not recur. Failure to do so may result in regulatory action without further notice such as seizure and/or injunction.
 
You should notify this office in writing of the steps you have taken to bring your firm into compliance with the law within fifteen (15) working days of receiving this letter. Your response should include each step that has been taken or will be taken to correct the violations and prevent their recurrence. If corrective action cannot be completed within fifteen (15) working days of receiving this letter, state the reason for the delay and the time frame within which the corrections will be completed. Please include copies of any available documentation demonstrating that corrections have been made.
 
Your written response should be sent to Richard C. Cherry, Compliance Officer, U.S. Food and Drug Administration, U.S. Customhouse, Room 900, 200 Chestnut Street, Philadelphia, Pennsylvania 19106. If you have any questions about this letter, please contact Compliance Officer Richard C. Cherry at (215)717-3075 or by e-mail at Richard.Cherry@fda.hhs.gov.
 
Sincerely,
/S/ 
Kirk D. Sooter
District Director
Philadelphia District
 
 
cc: Barbara E. Fisher, Co-owner
      Samuel A. Fisher Farm
      2100 Stiegel Pike
      Myerstown, PA 17067
 
      Dr. Isabel Arrington, Director TA/C
      United States Department of Agriculture (USDA)
      Food Safety and Inspection Service (FSIS)
      Office of Policy and Program Development
      1616 Capitol Avenue, Suite 260
      Omaha, Nebraska 68102
 
      Dr. David R. Griswold, Acting Director
      Pennsylvania Department of Agriculture
      Bureau of Animal Health and Diagnostic Services (BAHDS)
      2301 Cameron Street
      Harrisburg, Pennsylvania 17120
 
      Dr. Thomas Alexander
      Chief of Regulation and Compliance
      Pennsylvania Department of Agriculture
      Bureau of Animal Health
      Room 408
      2301 North Cameron Street
      Harrisburg, Pennsylvania 17110